Cargando…
PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
Mitotic kinases are the key components of the cell cycle machinery and play vital roles in cell cycle progression. PLK-1 (Polo-like kinase-1) is a crucial mitotic protein kinase that plays an essential role in both the onset of G2/M transition and cytokinesis. The overexpression of PLK-1 is strongly...
Autores principales: | Kumar, Shiv, Kim, Jaebong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628734/ https://www.ncbi.nlm.nih.gov/pubmed/26557691 http://dx.doi.org/10.1155/2015/705745 |
Ejemplares similares
-
Regulatory functional territory of PLK-1 and their substrates beyond mitosis
por: Kumar, Shiv, et al.
Publicado: (2017) -
PLK1, A Potential Target for Cancer Therapy
por: Liu, Zhixian, et al.
Publicado: (2016) -
Upregulation of PAIP1 promotes the gallbladder tumorigenesis through regulating PLK1 level
por: Bi, Jianping, et al.
Publicado: (2021) -
Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
por: Yi, You-Cai, et al.
Publicado: (2021) -
Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012)